ES2142430T3 - Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. - Google Patents

Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.

Info

Publication number
ES2142430T3
ES2142430T3 ES95111876T ES95111876T ES2142430T3 ES 2142430 T3 ES2142430 T3 ES 2142430T3 ES 95111876 T ES95111876 T ES 95111876T ES 95111876 T ES95111876 T ES 95111876T ES 2142430 T3 ES2142430 T3 ES 2142430T3
Authority
ES
Spain
Prior art keywords
oral administration
chondroitin sulphate
gel containing
pharmaceutical compounds
containing salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95111876T
Other languages
English (en)
Inventor
Luca Nocelli
Elisabetta Donati
Paolo Lualdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IBSA Institut Biochimique SA
Original Assignee
IBSA Institut Biochimique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IBSA Institut Biochimique SA filed Critical IBSA Institut Biochimique SA
Application granted granted Critical
Publication of ES2142430T3 publication Critical patent/ES2142430T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS DE TIPO GEL, TOTALMENTE SOLUBLES EN AGUA QUE CONTIENEN UNA CANTIDAD TERAPEUTICAMENTE EFICAZ O AL MENOS UNA SAL DE SULFATO DE CONDROITINA, PARTICULARMENTE IDONEO PARA SU ADMINISTRACION ORAL EN EL TRATAMIENTO DE LA ARTROSIS, Y QUE CONTIENE ADEMAS DE 3 A 20 G., 1 A 5 G. DE UN AGENTE EDULCORANTE, Y 1 A 20 MG. DE UN AGENTE DE SABOR POR GRAMO DEL PRINCIPIO ACTIVO.
ES95111876T 1994-09-28 1995-07-28 Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. Expired - Lifetime ES2142430T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941974A IT1270095B (it) 1994-09-28 1994-09-28 Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale

Publications (1)

Publication Number Publication Date
ES2142430T3 true ES2142430T3 (es) 2000-04-16

Family

ID=11369610

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95111876T Expired - Lifetime ES2142430T3 (es) 1994-09-28 1995-07-28 Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.

Country Status (7)

Country Link
EP (1) EP0704216B1 (es)
AT (1) ATE187334T1 (es)
DE (1) DE69513767T2 (es)
ES (1) ES2142430T3 (es)
GR (1) GR3032874T3 (es)
IT (1) IT1270095B (es)
PT (1) PT704216E (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
FR2770777B1 (fr) * 1997-11-10 2000-02-25 Fabre Pierre Dermo Cosmetique Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie
ES2210705T5 (es) * 1998-03-19 2011-02-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo.
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery
WO2000044367A2 (en) 1999-02-01 2000-08-03 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
AU2001266648A1 (en) * 2000-06-02 2001-12-17 The Procter And Gamble Company Kits and methods for optimizing the efficacy of chondroprotective compositions
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
AU2001269730A1 (en) * 2000-06-02 2001-12-17 The Procter And Gamble Company Low carbohydrate compositions, kits thereof, and methods of use
ES2167251B1 (es) * 2000-07-13 2003-09-16 Bioiberica Nuevos disacaridos con accion antiartrosica.
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ITMI20032614A1 (it) * 2003-12-30 2005-06-30 Altergon Sa Nuova composizione comprendente cs
ITMI20071120A1 (it) 2007-06-01 2008-12-02 Apharm Srl Composizione antiartrosica
FR2936712B1 (fr) * 2008-10-02 2011-07-01 Mds Lab Composition pour la prevention et/ou le traitement de l'arthrose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03500168A (ja) * 1988-06-27 1991-01-17 ライナー　ローラント 医薬の製造の為のグリコースアミノグリカンの使用
JP3207587B2 (ja) * 1993-03-04 2001-09-10 株式会社紀文フードケミファ 徐放性組成物

Also Published As

Publication number Publication date
EP0704216A1 (en) 1996-04-03
EP0704216B1 (en) 1999-12-08
DE69513767T2 (de) 2000-08-10
DE69513767D1 (de) 2000-01-13
ITMI941974A0 (it) 1994-09-28
ITMI941974A1 (it) 1996-03-28
PT704216E (pt) 2000-05-31
IT1270095B (it) 1997-04-28
GR3032874T3 (en) 2000-07-31
ATE187334T1 (de) 1999-12-15

Similar Documents

Publication Publication Date Title
ES2142430T3 (es) Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
Tradati et al. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR)
CO5190689A1 (es) Sales de tramadol formadas por tramadol y un edulcorante y formas farmaceuticas que contienen dichas sales
US6828308B2 (en) Compositions and methods for the treatment or prevention of inflammation
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
ES2125099T3 (es) Composiciones que comprenden nanoparticulas de un antiinflamatorio no estereoideo.
NZ508037A (en) A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
ES2160693T3 (es) Formulacion estable de 10-hidroxi-7-etil-camptotecina en la forma lactona.
ES2255287T3 (es) Composiciones para el tratamiento de la leucemia linfocitica cronica.
IT1296980B1 (it) Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
CN101951877A (zh) 用于治疗口腔干燥的组合物和方法
ATE295160T1 (de) Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
Lockhart et al. Antibiotic considerations in medically compromised patients
WO2006095363A3 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts
AR041069A1 (es) Composicion de tolterodina liquida oral
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
ES2115571T3 (es) Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas.
JP2003503453A5 (ja) ガバペンチンおよびプレガバリンを含む相乗作用組成物
CO5640085A2 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
KR870009716A (ko) 클로르페니라민 제형

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 704216

Country of ref document: ES